Q4 2015
Released Mar 14, 2016, after the close
10-K filed Mar 14, 2016, 74 days after period end · 0001144204-16-087765
Q4 2015 · 10-K
Revenue$2.50K$2.50K −46.4% vs Q4 2014±0.0% vs Q3 2015
Net Income-$4.77M-$4.77M N/M vs Q4 2014N/M vs Q3 2015
EPS Diluted-$0.05-$0.05 N/M vs Q4 2014N/M vs Q3 2015
Operating Income-$4,351,306N/M
Operating Cash Flowderived-$3,899,262N/M
Free Cash Flowderived-$3,947,321N/M
Margins · derived
Operating margin-174052.2%−74588.8 pt vs Q4 2014
Net margin-190606.0%−72664.2 pt vs Q4 2014
What the release said
The release
Same quarter
| Metric | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|
| Revenue | $2.50K | $4.67K | $2.50K | $2.50K |
| Net Income | -$4.77M | -$5.50M | -$3.30M | -$2.71M |
| EPS Diluted | -$0.05 | -$0.06 | -$0.04 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR